Significant progress has been made in the clinical management of a variety of
cardiovascular diseases. Nevertheless, the therapeutic efficacy of the current treatment …

Introduction. The FSAP-Marburg I polymorphism (1704G> A), which reduces FSAP activity,
is associated with late complications of carotid stenosis in humans. Therefore, this study …

Proinflammatory cytokines, like interleukin‐6 (IL‐6) and tumor necrosis factor‐alpha (TNF‐
α), are implicated in the development of atherosclerosis. The role of anti‐inflammatory …

Objective: Restenosis is the main drawback of percutaneous coronary intervention (PCI).
Inherited factors may explain part of the risk of restenosis. Recently, the vitamin D receptor …

Background Delirium is associated with substantial morbidity and mortality rates in elderly
hospitalised patients, and a growing problem due to increase in life expectancy …

Background—The cyclin-dependent kinase inhibitor p27kip1 is a key regulator of smooth
muscle cell and leukocyte proliferation in vascular disease, including in-stent restenosis. We …

Genetic factors appear to be important in the process of restenosis after percutaneous
coronary intervention (PCI), as well as in inflammation, a pivotal factor in restenosis. An …

The platelet receptor P2Y12 (gene symbol P2RY12) is involved in several processes that
contribute to restenosis after percutaneous coronary interventions (PCI). Therefore, common …

Aims This study was designed to investigate the counterbalancing influence of genetic
variation in the promoter of the gene encoding P300/CBP associated factor (PCAF), a lysine …

Objectives Genetic factors appear to be important in the development of restenosis after
percutaneous coronary intervention, as well as in the process of inflammation, a pivotal …